DD · Earnings call · 2026Q2T · Full report

Segment Profitability

DuPont de Nemours, Inc. · 2026-08-04 · Importance 49 · Surprise 32 · No source text

Second-quarter operating EBITDA was $448 million, up 8% year over year, and operating EBITDA margin expanded 80 basis points to 24.6%. Healthcare & Water Technologies generated $258 million of operating EBITDA, up 4%, but its margin declined 30 basis points to 30.1% because favorable organic growth and productivity were more than offset by mix and growth investments. Diversified Industrials generated $213 million of operating EBITDA, up 7%, and margin expanded 70 basis points to 22.1% on organic growth, favorable mix, and productivity. Price/cost was dollar-neutral, with approximately $90 million of full-year pricing primarily expected in the second half to offset oil and gas-related costs.

Key facts

• Company indicated incrementals (operating leverage) in the second half are around 40% when adjusted for price/cost dynamics.
• Q2 2026 operating EBITDA: $448 million, increased 8% versus the year ago period.
• Healthcare & Water Technologies Q2 2026 operating EBITDA: $258 million, up 4% versus the year ago period; operating EBITDA margin 30.1% decreased 30 basis points year-over-year.
• Diversified Industrials Q2 2026 operating EBITDA: $213 million, up 7% versus the year ago period; operating EBITDA margin 22.1%, an increase of 70 basis points versus the year ago period.
• Q2 2026 operating EBITDA margin: 24.6%, an increase of 80 basis points year-over-year, including a 30 basis point headwind from price/cost dynamics.
• Adjusted EPS for Q2 2026: $1.88, up 21% versus the year ago period.

Impact estimates